A Comparative Study of Upconverting Nanoparticles Versus Lentiviral GFP Transduction for Labeling Mesenchymal Stem Cells

Similar documents
Supporting Information. Templated Repair of Long Bone Defects in Rats. with Bioactive Spiral-Wrapped Electrospun

Stem cell labeling using polyethylenimine conjugated (alpha-naybf4:tm3+)/caf2 upconversion nanoparticles

Quantum Dot Labeling of Stem Cells during Proliferation and Differentiation

Cross-Linker Modulation to Maintain Phenotype of RGD-Alginate-Embedded Mesenchymal Stem Cells

Application Note. Introduction. Kerry Thompson, Jeff Partridge, Paula Flaherty, Susan Qian, and Deepa Saxena

Mesenchymal Progenitor Cells (MPCs) Involvement In Ectopic Fat Formation In Muscular Dystrophy

User Manual. OriCell TM Rabbit Mesenchymal Stem Cells (MSCs) Cat. No. RBXMX-01001

Primary Cilia Are Essential For Maintaining Bone Marrow Stromal Cells In Their In Situ Environment

Pittsburgh Tissue Engineering Initiative Annual Progress Report: 2011 Formula Grant

Supplemental Information. Materials and methods.

User Manual. OriCell TM Balb/c Mouse Mesenchymal Stem Cells with GFP(MSCs/GFP) Cat. No. MUCMX-01101

Seevix s SVXgro: A Spidersilk Scaffold for Tissue Engineering

Heparanase Modulates Chondrogenic Factor Signaling And Is Upregulated In Ectopic Cartilage

Gaussia Luciferase-a Novel Bioluminescent Reporter for Tracking Stem Cells Survival, Proliferation and Differentiation in Vivo

TRANSFEX - SUPERIOR GENE EXPRESSION FOR HARD-TO-TRANSFECT CELL TYPES. Kevin Grady Product Line Business Manager ASCB Vendor Showcase Dec.

Aptamer-Functionalized Delivery System for Osteogenic sirnas to Achieve Osteoblast- Specific RNA Interference for Bone Anabolic Therapy

Evaluation of RNA interference (RNAi) in Skin

User Manual. OriCell TM C57BL/6 Mouse Adipose-derived Mesenchymal Stem Cells With GFP (ADSCs/GFP) Cat. No. MUBMD-01

User Manual. OriCell TM Strain C57BL/6 Mouse Mesenchymal Stem Cells with GFP (MSCs/GFP) Cat. No. MUBMX-01101

User Manual. OriCell TM Dog Adipose-Derived Mesenchymal. Stem Cells (ADSCs) Cat. No. CAXMD-01001

A NANOFIBROUS HYDROGEL FOR BONE TISSUE ENGINEERING

Pre-made Lentiviral Particles for Nuclear Permeant CRE Recombinase Expression

Attenuation of MSC Hypertrophy in 3D Culture via Treatment with a Retinoic Acid Receptor Inverse Agonist

Poietics Rat Mesenchymal Stem Cells Instructions for Use

Pittsburgh Tissue Engineering Initiative Annual Progress Report: 2010 Formula Grant

Development of Novel Advanced Cell Culture Surfaces that Provide Better Cell Growth and Attachment for Cell-Based Assays

Ips Cells Can Be Efficiently Differentiated Back To Mscs Using A Short Exposure To Tgfβ

Your Power for Health. Magnetic cell culturing. The n3d approach

Serum-Free, Xeno-Free Differentiation Media. for Human Mesenchymal Stem Cells

Formation of Mesenchymal Tissues in Alvetex Scaffold Derived From Stem Cells and Established Cell Lines. Introduction

CHAPTER 8. orthopaedic and bone tissue engineering applications.

Rapid Chromatin Condensation Increases Stem Cell Nuclear Mechanics and Mechanosensitivity

Cell Viability and Senescence Detection Kits

Assuring Multipotency of human Mesenchymal Stem Cells (hmsc)

Supplementary Information Temperature-responsive Gene Silencing by a Smart Polymer

User Manual. OriCellTM Strain C57BL/6 Mouse Mesenchymal Stem Cells with RFP(MSCs/RFP) Cat. No. MUBMX-01201

Culture of human mesenchymal stem cells in Nunc Cell Factory systems

Pre-made Reporter Lentivirus for p53 Signal Pathway

Trimethylamine N-Oxide Media Supplementation for Cartilage Tissue Engineering of Synovium-Derived Stem Cells

Cultrex Rat Mesenchymal Stem Cell Growth and Differentiation Products

UK +44 (0) CH +41 (0) DE +49 (0) US

HDF Cell Proliferation and Attachment in Vitro

User Manual. OriCell TM Human Umbilical Cord Blood Mesenchymal Stem Cells. Cat. No. HUXUB-01001

Brightfield and Fluorescence Imaging using 3D PrimeSurface Ultra-Low Attachment Microplates

Determination of Superior Culture Conditions for HDF Cells BIOE /28/08

Osteogenic Differentiation and Analysis of MSC

Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis

Real Time Cell Electronic Sensing (RT-CES) for Nanotoxicity Evaluation

Mesenchymal stem cell culture Flow cytometry Analysis and improvement of the cell modification using flow cytometry Site density determination

NF-κB/Jurkat/GFP Transcriptional Reporter Cell Line

The Effects of Different Sources of Fetal Bovine Serum on Chondrocyte Growth

Assessment of Polymer Wafer Aided Gene Transfection. Efficiency and Cell Viability

Cellartis MSC Xeno-Free Culture Medium

5.4 PERIODONTAL LIGAMENT STEM CELL (PDLSC) ISOLATION. Having validated that the isolated PDL stromal cells possessed the major phenotypic

Qi Peng, Fujie Chen, Zhenlin Zhong,* Renxi Zhuo

Chondrocyte Response To Prp Is Concentration-Dependent

Harnessing Endogenous Stem/Progenitor Cells for Tendon Regeneration: Lee et al., 2015

Supporting Information. Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis,

Mesenchymal Stem Cell Characterization. Peiman Hematti, M.D. Department of Medicine

The Osteogenic Action Of Erythropoietin On Human Mesenchymal Stromal Cells

Lyset BOOST YOUR CELL CULTURE TODAY FOR THE EXPERIMENTS OF TOMORROW

Characterization of Human MSCs Cultured in MesenCult -XF

CHAPTER 4 IN VITRO CYTOTOXICITY ASSAY ON GOLD NANOPARTICLES WITH DIFFERENT STABILIZING AGENT

Supplementary Information (Ha, et. al) Supplementary Figures Supplementary Fig. S1

User Manual. OriCell TM Human Umbilical Cord Blood Mesenchymal Stem Cells. Cat. No. HUXUB-01001

User Manual. OriCell TM Human Umbilical Cord Mesenchymal Stem Cells. Cat. No. HUXUC-01001

User Manual. OriCell TM Human Umbilical Cord Mesenchymal Stem Cells. Cat. No. HUXUC-01001

Instructions For Research Use Only. Not For Use In Diagnostic Procedures. Rat Mesenchymal Stem Cell Starter Kit. Rat Mesenchymal Stem Cell Starter Kit

User Manual. OriCell TM Mesenchymal Stem Cell Osteogenic Differentiation Medium. Cat. No. GUXMX-90021

Studying the cellular uptake and toxicity of CMP NPs

Instructions For Research Use Only. Not For Use In Diagnostic Procedures. Rat Mesenchymal Stem Cells. Rat Mesenchymal Stem Cells.

Marilyn G. Rimando, Hao-Hsiang Wu, Yu-An Liu, Chien-Wei Lee, Shu-Wen Kuo, Yin-

Mag4C-Lv Kit - Results

Mesenchymal Stem/Stromal Cells

User Manual. OriCell TM Sprague-Dawley (SD) Rat Mesenchymal Stem Cells with RFP (MSCs/RFP) Cat. No. RASMX-01201

Mag4C-Ad Kit - Results

User Manual. OriCell TM Strain C57BL/6 Mouse Mesenchymal Stem Cells with GFP (MSCs/GFP) Cat. No. MUBMX-01101

THE EFFECTS OF POLYETHYLENE PARTICLE PHAGOCYTOSIS ON THE VIABILITY OF MATURE HUMAN MACROPHAGES BY PETER ASPINALL, KYRA BURNETT, JOE MAHER, CAT TJAN

Effects Of Hypoxia-conditioned Medium On MSC Chondrogenesis

The Effects of Iron Oxide Nanoparticle on Differentiation of Human Mesenchymal Stem Cells to Osteoblast

PROTOCOL. Live Cell Imaging of 3D Cultures Grown on Alvetex Scaffold Using Confocal Microscopy. Introduction

Protocol Using a Dox-Inducible Polycistronic m4f2a Lentivirus to Reprogram MEFs into ips Cells

Trace: Tennessee Research and Creative Exchange. University of Tennessee, Knoxville

T ECHNICAL MANUAL. Culture of Human Mesenchymal Stem Cells Using MesenCult -XF Medium

ab CFSE Fluorescent Cell Labeling Kit

Quantitative real-time RT-PCR analysis of the expression levels of E-cadherin

Disclosures: A.W. Su: None. D.H. Wailes: None. Y. Chen: None. V. Wong: None. E. Cory: None. A.C. Chen: None. W.D. Bugbee: None. R. Sah: None.

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Fluorescence Microscopy. Terms and concepts to know: 10/11/2011. Visible spectrum (of light) and energy

Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia

TOOLS sirna and mirna. User guide

Normalization of Agilent Seahorse XF Data by In-situ Cell Counting Using a BioTek Cytation 5

Y 2 O 3 Nanoparticles Caused Bone Tissue Damage by Breaking the Intracellular Phosphate Balance in Bone Marrow Stromal Cells

PRIME-XV Cell Therapy Products by

LentiBoost TM Lentiviral Transduction Enhancer

Supplementary Information. Conversion of vascular endothelial cells into multipotent stem-like cells

CellPlayer CytoLight Green (Lenti, CMV, no selection)

Xfect Protein Transfection Reagent

Human Bone Marrow Derived Mesenchymal Stem Cell (MSC) Care Manual

Transcription:

A Comparative Study of Upconverting Nanoparticles Versus Lentiviral GFP Transduction for Labeling Mesenchymal Stem Cells Artem Kutikov, B.S., Liang Zhao, Gang Han, Ph.D., Jie Song, Ph.D.. University of Massachusetts Medical School, Worcester, MA, USA. Disclosures: A. Kutikov: None. L. Zhao: None. G. Han: None. J. Song: None. Introduction: Bone marrow-derived mesenchymal stem cells (MSCs) are multipotent cells that have shown great promise for bone and cartilage tissue repair and regeneration. Exogenous MSCs, delivered via a biomaterial scaffold/carrier to a tissue defect, may expedite healing through the secretion of soluble factors, proliferation and differentiation into other cell types, or a combination of both. To fully understand how these exogenously delivered stem/progenitor cells participate in tissue repair in a spatially and temporally defined manner, real-time in vivo tracking of these cells using suitable imaging probes that do not interfere with normal cellular functions is desired. Organic dyes, fluorescent proteins, or fluorescent nanoparticles have been traditionally explored for cellular tracking. However, such approaches typically suffer from poor imaging characteristics (e.g. limited tissue penetration depth, tissue autofluorescence). Recently, upconverting nanoparticles (UCNPs) that can absorb and emit near-infrared light, thereby minimizing soft tissue background and enabling deeper tissue penetration than conventional imaging probes, have been developed. 1 Such UCNPs are being investigated for labeling and tracking MSCs, 2 and explored as potential tools for orthopedic tissue engineering applications. To enable these investigations, direct comparison of how UCNP labeling of MSCs vs. the more widely used technique of fluorescent protein expression impacts the cellular viability, proliferation and differentiation is necessary, yet has not been carried out. Here we compare the performance of polyethylenimine (PEI)- conjugated (α-naybf 4 :Tm 3+ )/CaF 2 UCNPs vs. lentiviral transduction of green fluorescent protein (GFP) for labeling rat bone marrow-derived MSCs (rmscs). Specifically, we examined the effect of varying UCNP loading doses on MSC labeling efficiency, cell viability, proliferation, and osteogenic and adipogenic differentiation in vitro. Meanwhile, we compared three constitutive promoters and a range of lentiviral loads for optimal GFP transduction efficiency and minimal cytotoxicity in rmscs. The impact of GFP-transduction on rmsc proliferation and differentiation in vitro is compared with UCNP labeling. Methods: α-(naybf 4 :0.5% Tm 3+ )/CaF 2 UCNPs were synthesized as previously described 1. PEI (MW 25KD) was conjugated to the surface of the UCNPs by ligand exchange and subsequent covalent linkage to poly(acrylic acid). UCNPs were added to passage 1 rmscs at concentrations of 0, 20, 50, or 100 µg/ml in MSC expansion media (αmem + 20% FBS + 1% L-Glutamine + 1% Pen- Strep). Following a 24-h exposure, the particles were removed by 3 washes with PBS. The cells were fixed in 3.7% methanol-free formaldehyde in PBS and imaged with a 2-photon microscope (Zeiss LSM 7 MP, 980nm excitation). To determine the cytotoxicity of the UCNPs, an MTT cell viability assay was performed at 24 h after UCNP exposure at varying doses. The viability of untreated rmscs was used a control. To optimize the GFP lentiviral transduction in rmscs, the ubiquitous promoters Ubiquitin C (UBC), cytomegalovirus (CMV), and human elongation factor-1 alpha (EF1α) were tested at three multiplicities of infection (MOI: 5, 25, 50). Passage 1 rmscs were seeded at a density of ~10,000 cells/cm 2 in transduction media (αmem, 20% heat-inactivated FBS, 1% L-Glutamine) and cultured for 24 h before the respective lentiviral vectors (Cellomics Technology) were added. The plates were spun for 30 min (1200 g, 32 ºC) to increase transduction efficiency. After 24-h transduction, the media were changed to expansion media (αmem, 20% FBS, 1% L-Glutamine, 1% Pen-Strep) and cells were cultured for an additional 24 h before being imaged on an epifluorescence microscope (Zeiss Axiovert 40 CFL). Viability of cells was determined at 24 h following the lentiviral transduction of rmscs by EF1α-GFP. For both UCNP and GFP treated cells, proliferation was determined by MTT assay over 72 h and presented as fold of changes over the initial viable cells. Osteogenic and adipogenic differentiations were performed by incubating the UCNP-rMSCs, GFP-rMSCs, or untreated rmscs in osteogenic or adipogenic media 2 for 14 days. Alizarin red O and oil red O staining was performed to assess the potency of osteogenic and adipogenic differentiation, respectively. Results: Uptake of PEI-conjugated UCNPs by the rmscs positively correlated with the UCNP exposure doses (Fig. 1A). The PEIcoated particles appear to be distributed within the cytoplasm with some degrees of clustering but not inside the cell nucleus. At a concentration of 100 µg/ml, over 90% of the rmscs were labeled with UCNPs. Lentiviral vectors were chosen for the GFP transduction due to their stable integration into the genome. Coupled with a ubiquitously expressed promoter, the GFP should be continuously expressed throughout cell division and differentiation. Of the lentiviral vectors with GFP driven by UBC, CMV, and EF1α promoters, CMV and EF1α led to the higher levels of GFP transduction in rmscs, with EF1α providing the most uniform GFP signal (Fig. 1B). GFP intensity increased with increasing MOI. Both the UCNP and GFP-based methods were able to label a high percentage of cells. Unlike the internalized UCNP particles, the GFP signal appeared to be more evenly distributed throughout the cell, enabling individual cells to be readily identified without requiring a counterstain of the cell nuclei. The MTT cell viability assay revealed that the rmsc viability dropped with increasing UCNP treatment dose. At the dose of 100

µg/ml, which resulted in the best UCNP labeling efficiency, only 63% of cells were viable by 24 h compared to the untreated control (Fig. 1C). By contrast, greater than 90% of the GFP-labeled rmscs were viable at the highest multiplicity of infection (MOI=50) (Fig. 1D). The viable UCNP- or GFP-labeled rmscs underwent normal proliferation over a 72-h period compared to unlabeled controls (Fig. 1E). Both UCNP- and GFP-labeled rmscs were able to differentiate into adipocytes and osteoblast upon culture induction, although the osteogenesis of UCNP-labeled cells appear to be noticeably compromised. 2 Quantitative comparison of the responses of these labeled rmscs to osteogenic and adipogenic inductions are undergoing. Discussion: The favorable imaging characteristics of UCNPs (tissue penetration, low background, stable signal) make them promising tools for tracking the fate of transplanted MSCs in tissue engineering. However, whereas high cytoplasmic labeling efficiency (>90%) of rmscs can be achieved with both PEI-coated UCNPs and lentiviral GFP transduction, further optimization of the UCNP-labeling is required to reduce the initial cytotoxicity and negative impact on osteogenic differentiation. Compared to the UCNP labeling, the GFP signal is also more evenly distributed within the cytoplasm and the individual cells can be identified more readily than UCNP labeled cells in vitro. These data suggest that developing UCNP coatings with reduced cytotoxicity and tendency for particle aggregation would be important for their application in MSC tracking. Significance: Successful development of cytocompatible UCNP labels for MSCs can enable the long-term tracking of cell fate to gain mechanistic insight of their role in bone tissue regeneration. Acknowledgments: This work was supported by the University of Massachusetts Medical School and NIH grant R01AR055615. References: 1. Chen G, Shen J, Ohulchanskyy TY, et al. ACS nano. 2012;6(9):8280-7.

2. Zhao L, Kutikov A, Shen J, Duan C, Song J, Han G. Theranostics. 2013;3(4):249-

ORS 2014 Annual Meeting Poster No: 0307